// App-Quantinova.ai

: A combination of both testosterone and white blood count as predictive factors of overall survival in localized prostate cancer.

Researchers

Presenter

  • Daniel Taussky

Principal Investigators

  • Denis Soulieres

  • Laurent Azoulay

  • Hui Yin

  • Houda Bahig

  • Jean-Paul Bahary

  • Guila Delouya

Medical Centers

  • Department of Radiation Oncology, Centre Hospitalier de lUniversite de Montreal, Montreal University, Montreal, QC, Canada

  • Centre Hospitalier de LUniversite de Montreal (CHUM), Montreal, QC, Canada

  • Centre for Clinical Epidemiology, Jewish General Hospital, Montreal, QC, Canada

  • Centre Hospitalier Universite de Montreal- Hopital Notre Dame, Montreal, QC, Canada

  • Centre Hospitalier de l'Universite de Montreal, Montreal University, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • White Blood Cell

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved